Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population

REFERENCES

• Feigelson, H.S.; Henderson, B.E. Estrogens and breast cancer. Carcinogenesis 1996, 17(11), 2279–2284.
   PubMed Web of Science ®Google Scholar
• Peto, J.; Collins, N.; Barfoot, R.; Seal, S.; Warren, W.; Rahman, N.; Easton, D.F.; Evans, C.; Deacon, J.; Stratton, M.R. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999, 91(11), 943–949.
   PubMed Web of Science ®Google Scholar
• Spurdle, A.B.; Hopper, J.L.; Dite, G.S.; Chen, X.; Cui, J.; McCredie, M.R.; Giles, G.G.; Southey, M.C.; Venter, D.J.; Easton, D.F.; Chenevix-Trench, G. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 2000, 92(20), 1674–1681.
   PubMed Web of Science ®Google Scholar
• Figueiredo, J.C.; Knight, J.A.; Briollais, L.; Andrulis, I.L.; Ozcelik, H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2004, 13(4), 583–591.
   PubMed Web of Science ®Google Scholar
• Han, J.; Hankinson, S.E.; Ranu, H.; De Vivo, I.; Hunter, D.J. Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis 2004, 25(2), 189–195.
   PubMed Web of Science ®Google Scholar
• Millikan, R.; Pittman, G.; Tse, C.K.; Savitz, D.A.; Newman, B.; Bell, D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2000, 9(6), 567–573.
   PubMed Web of Science ®Google Scholar
• Shen, J.; Desai, M.; Agrawal, M.; Kennedy, D.O.; Senie, R.T.; Santella, R.M.; Terry, M.B. Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev 2006, 15(9), 1614–1619.
   PubMed Web of Science ®Google Scholar
• Syamala, V.S.; Sreeja, L.; Syamala, V.; Raveendran, P.B.; Balakrishnan, R.; Kuttan, R.; Ankathil, R. Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam Cancer 2008, 7(3), 213–220.
   PubMed Web of Science ®Google Scholar
• Colditz, G.A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998, 90(11), 814–823.
   PubMed Web of Science ®Google Scholar
• Beato, M. Gene regulation by steroid hormones. Cell 1989, 56(3), 335–344.
   PubMed Web of Science ®Google Scholar
• Service, R.F. New role for estrogen in cancer?. Science 1998, 279(5357), 1631–1633.
   PubMed Web of Science ®Google Scholar
• Carey, A.H.; Waterworth, D.; Patel, K.; White, D.; Little, J.; Novelli, P.; Franks, S.; Williamson, R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994, 3(10), 1873–1876.
   PubMed Web of Science ®Google Scholar
• Feigelson, H.S.; Shames, L.S.; Pike, M.C.; Coetzee, G.A.; Stanczyk, F.Z.; Henderson, B.E. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998, 58(4), 585–587.
   PubMed Web of Science ®Google Scholar
• Yager, J.D.; Liehr, J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996, 36, 203–232.
   PubMed Web of Science ®Google Scholar
• Zhu, B.T.; Conney, A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998, 19(1), 1–27.
   PubMed Web of Science ®Google Scholar
• Kawajiri, K.; Nakachi, K.; Imai, K.; Yoshii, A.; Shinoda, N.; Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990, 263(1), 131–133.
   PubMed Web of Science ®Google Scholar
• Kiyohara, C.; Hirohata, T.; Inutsuka, S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 1996, 87(1), 18–24.
   PubMedGoogle Scholar
• Liehr, J.G.; Avitts, T.A.; Randerath, E.; Randerath, K. Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc Natl Acad Sci USA 1986, 83(14), 5301–5305.
   PubMed Web of Science ®Google Scholar
• Cavalieri, E.L.; Stack, D.E.; Devanesan, P.D.; Todorovic, R.; Dwivedy, I.; Higginbotham, S.; Johansson, S.L.; Patil, K.D.; Gross, M.L.; Gooden, J.K.; Ramanathan, R.; Cerny, R.L.; Rogan, E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997, 94(20), 10937–10942.
   PubMed Web of Science ®Google Scholar
• Roy, A.K.; Upadhyaya, P.; Evans, F.E.; el-Bayoumy, K. Structural characterization of the major adducts formed by reaction of 4,5-epoxy-4,5-dihydro-1-nitropyrene with DNA. Carcinogenesis 1991, 12(4), 577–581.
   PubMed Web of Science ®Google Scholar
• Raftogianis, R.; Creveling, C.; Weinshilboum, R.; Weisz, J. Estrogen metabolism by conjugation. J Natl. Cancer Inst Monogr 2000, ( 27), 113–124.
   PubMedGoogle Scholar
• Cavalieri, E.; Frenkel, K.; Liehr, J.G.; Rogan, E.; Roy, D. Estrogens as endogenous genotoxic agents—DNA adducts and mutations. J Natl Cancer Inst Monogr 2000, (27), 75–93.
   PubMedGoogle Scholar
• Adjei, A.A.; Weinshilboum, R.M. Catecholestrogen sulfation: possible role in carcinogenesis. Biochem Biophys Res Commun 2002, 292(2), 402–408.
   PubMed Web of Science ®Google Scholar
• Weinshilboum, R.M.; Otterness, D.M.; Aksoy, I.A.; Wood, T.C.; Her, C.; Raftogianis, R.B. Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. FASEB J 1997, 11(1), 3–14.
   PubMed Web of Science ®Google Scholar
• Falany, J.L.; Falany, C.N. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 1996, 56(7), 1551–1555.
   PubMed Web of Science ®Google Scholar
• Raftogianis, R.B.; Wood, T.C.; Otterness, D.M.; Van Loon, J.A.; Weinshilboum, R.M. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 1997, 239(1), 298–304.
   PubMed Web of Science ®Google Scholar
• IARC. IARC Monographs on the evaluation of carcinogenic risks to humans: diesel and gasoline engine exhausts and some nitroarenes. Lyon 1989, 43, 41–185.
   Google Scholar
• Lavigne, J.A.; Helzlsouer, K.J.; Huang, H.Y.; Strickland, P.T.; Bell, D.A.; Selmin, O.; Watson, M.A.; Hoffman, S.; Comstock, G.W.; Yager, J.D. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997, 57(24), 5493–5497.
   PubMed Web of Science ®Google Scholar
• Sparks, R.; Ulrich, C.M.; Bigler, J.; Tworoger, S.S.; Yasui, Y.; Rajan, K.B.; Porter, P.; Stanczyk, F.Z.; Ballard-Barbash, R.; Yuan, X.; Lin, M.G.; McVarish, L.; Aiello, E.J.; McTiernan, A. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 2004, 6(5), R488–R498.
   PubMed Web of Science ®Google Scholar
• Ambrosone, C.B.; Moysich, K.B.; Furberg, H.; Freudenheim, J.L.; Bowman, E.D.; Ahmed, S.; Graham, S.; Vena, J.E.; Shields, P.G. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors. Breast Cancer Res 2003, 5(2), R45–R51.
   PubMed Web of Science ®Google Scholar
• Hayashi, S.I.; Watanabe, J.; Nakachi, K.; Kawajiri, K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acid Res 1991, 19(17), 4797.
   PubMed Web of Science ®Google Scholar
• Agarwal, G.; Pradeep, P.V.; Aggarwal, V.; Yip, C.H.; Cheung, P.S. Spectrum of breast cancer in Asian women. World J Surg 2007, 31(5), 1031–1040.
   PubMed Web of Science ®Google Scholar
• Houlston, R.S.; Peto, J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004, 23(38), 6471–6476.
   PubMed Web of Science ®Google Scholar
• Taioli, E.; Trachman, J.; Chen, X.; Toniolo, P.; Garte, S.J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 1995, 55(17), 3757–3758.
   PubMed Web of Science ®Google Scholar
• Bailey, L.R.; Roodi, N.; Verrier, C.S.; Yee, C.J.; Dupont, W.D.; Parl, F.F. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 1998, 58(1), 65–70.
   PubMed Web of Science ®Google Scholar
• Ishibe, N.; Hankinson, S.E.; Colditz, G.A.; Spiegelman, D.; Willett, W.C.; Speizer, F.E.; Kelsey, K.T.; Hunter, D.J. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res 1998, 58(4), 667–671.
   PubMed Web of Science ®Google Scholar
• Huang, C.S.; Chern, H.D.; Chang, K.J.; Cheng, C.W.; Hsu, S.M.; Shen, C.Y. Breast cancer risk associated with genotype polymorphism of the estrogen metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999, 59(19), 4870–4875.
   PubMed Web of Science ®Google Scholar
• Hefler, L.A.; Tempfer, C.B.; Grimm, C.; Lebrecht, A.; Ulbrich, E.; Heinze, G.; Leodolter, S.; Schneeberger, C.; Mueller, M.W.; Muendlein, A.; Koelbl, H. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 2004, 101(2), 264–269.
   PubMed Web of Science ®Google Scholar
• Chacko, P.; Joseph, T.; Mathew, B.S.; Rajan, B.; Pillai, M.R. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat Res 2005, 581(1–2), 153–163.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Millikan, R.C.; Bell, D.A.; Cui, L.; Tse, C.K.; Newman, B.; Conway, K. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. Breast Cancer Res 2005, 7(1), R12–R18.
   PubMed Web of Science ®Google Scholar
• Okobia, M.; Bunker, C.; Zmuda, J.; Kammerer, C.; Vogel, V.; Uche, E.; Anyanwu, S.; Ezeome, E.; Ferrell, R.; Kuller, L. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women. Breast Cancer Res Treat 2005, 94(3), 285–293.
   PubMed Web of Science ®Google Scholar
• Shen, Y.; Li, D.K.; Wu, J.; Zhang, Z.; Gao, E. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2006, 15(2), 342–347.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Wise, J.P.; Holford, T.R.; Xie, H.; Boyle, P.; Zahm, S.H.; Rusiecki, J.; Zou, K.; Zhang, B.; Zhu, Y.; Owens, P.H.; Zheng, T. Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol 2004, 160(12), 1177–1183.
   PubMed Web of Science ®Google Scholar
• Feigelson, H.S.; Coetzee, G.A.; Kolonel, L.N.; Ross, R.K.; Henderson, B.E. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997, 57(6), 1063–1065.
   PubMed Web of Science ®Google Scholar
• Dunning, A.M.; Healey, C.S.; Pharoah, P.D.; Foster, N.A.; Lipscombe, J.M.; Redman, K.L.; Easton, D.F.; Day, N.E.; Ponder, B.A. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer 1998, 77(11), 2045–2047.
   PubMed Web of Science ®Google Scholar
• Helzlsouer, K.J.; Huang, H.Y.; Strickland, P.T.; Hoffman, S.; Alberg, A.J.; Comstock, G.W.; Bell, D.A. Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 1998, 7(10), 945–949.
   PubMed Web of Science ®Google Scholar
• Weston, A.; Pan, C.F.; Bleiweiss, I.J.; Ksieski, H.B.; Roy, N.; Maloney, N.; Wolff, M.S. CYP17 genotype and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998, 7(10), 941–944.
   PubMed Web of Science ®Google Scholar
• Haiman, C.A.; Hankinson, S.E.; Spiegelman, D.; Colditz, G.A.; Willett, W.C.; Speizer, F.E.; Kelsey, K.T.; Hunter, D.J. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999, 59(5), 1015–1020.
   PubMed Web of Science ®Google Scholar
• Mitrunen, K.; Jourenkova, N.; Kataja, V.; Eskelinen, M.; Kosma, V.M.; Benhamou, S.; Vainio, H.; Uusitupa, M.; Hirvonen, A. Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 2000, 9(12), 1343–1348.
   PubMed Web of Science ®Google Scholar
• Chacko, P.; Rajan, B.; Mathew, B.S.; Joseph, T.; Pillai, M.R. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer. Breast Cancer 2004, 11(4), 380–388.
   PubMedGoogle Scholar
• Ahsan, H.; Whittemore, A.S.; Chen, Y.; Senie, R.T.; Hamilton, S.P.; Wang, Q.; Gurvich, I.; Santella, R.M. Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study. Breast Cancer Res 2005, 7(1), R71–R81.
   PubMed Web of Science ®Google Scholar
• Chang, J.H.; Gertig, D.M.; Chen, X.; Dite, G.S.; Jenkins, M.A.; Milne, R.L.; Southey, M.C.; McCredie, M.R.; Giles, G.G.; Chenevix-Trench, G.; Hopper, J.L.; Spurdle, A.B. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res 2005, 7(4), R513–R521.
   PubMed Web of Science ®Google Scholar
• Einarsdottir, K.; Rylander-Rudqvist, T.; Humphreys, K.; Ahlberg, S.; Jonasdottir, G.; Weiderpass, E.; Chia, K.S.; Ingelman-Sundberg, M.; Persson, I.; Liu, J.; Hall, P.; Wedren, S. CYP17 gene polymorphism in relation to breast cancer risk: a case-control study. Breast Cancer Res 2005, 7(6), R890–R896.
   PubMed Web of Science ®Google Scholar
• Little, J.; Simard, J. CYP17 and breast cancer: no overall effect, but what about interactions?. Breast Cancer Res 2005, 7(6), 238–242.
   PubMed Web of Science ®Google Scholar
• Shin, M.H.; Lee, K.M.; Yang, J.H.; Nam, S.J.; Kim, J.W.; Yoo, K.Y.; Park, S.K.; Noh, D.Y.; Ahn, S.H.; Kim, B.; Kang, D. Genetic polymorphism of CYP17 and breast cancer risk in Korean women. Exp Mol Med 2005, 37(1), 11–17.
   PubMed Web of Science ®Google Scholar
• Verla-Tebit, E.; Wang-Gohrke, S.; Chang-Claude, J. CYP17 5′-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population based case-control study. Breast Cancer Res 2005, 7(4), R455–R464.
   PubMed Web of Science ®Google Scholar
• Chakraborty, A.; Murthy, N.S.; Chintamani, C.; Bhatnagar, D.; Mohil, R.S.; Sharma, P.C.; Saxena, S. CYP17 gene polymorphism and its association with high risk north Indian breast cancer patients. J Hum Genet 2007, 52(2), 159–165.
   PubMed Web of Science ®Google Scholar
• Seth, P.; Lunetta, K.L.; Bell, D.W.; Gray, H.; Nasser, S.M.; Rhei, E.; Kaelin, C.M.; Iglehart, D.J.; Marks, J.R.; Garber, J.E.; Haber, D.A.; Polyak, K. Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 2000, 60(24), 6859–6863.
   PubMed Web of Science ®Google Scholar
• Zheng, W.; Xie, D.; Cerhan, J.R.; Sellers, T.A.; Wen, W.; Folsom, A.R. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10(2), 89–94.
   PubMed Web of Science ®Google Scholar
• Tang, D.; Rundle, A.; Mooney, L.; Cho, S.; Schnabel, F.; Estabrook, A.; Kelly, A.; Levine, R.; Hibshoosh, H.; Perera, F. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Treat 2003, 78(2), 217–222.
   PubMed Web of Science ®Google Scholar
• Langsenlehner, U.; Krippl, P.; Renner, W.; Yazdani-Biuki, B.; Eder, T.; Wolf, G.; Wascher, T.C.; Paulweber, B.; Weitzer, W.; Samonigg, H. Genetic variants of the sulfotransferase 1A1 and breast cancer risk. Breast Cancer Res Treat 2004, 87(1), 19–22.
   PubMed Web of Science ®Google Scholar
• Cheng, T.C.; Chen, S.T.; Huang, C.S.; Fu, Y.P.; Yu, J.C.; Cheng, C.W.; Wu, P.E.; Shen, C.Y. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 2005, 113(3), 345–353.
   PubMed Web of Science ®Google Scholar
• Choi, J.Y.; Lee, K.M.; Park, S.K.; Noh, D.Y.; Ahn, S.H.; Chung, H.W.; Han, W.; Kim, J.S.; Shin, S.G.; Jang, I.J.; Yoo, K.Y.; Hirvonen, A.; Kang, D. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(5), 1090–1095.
   PubMed Web of Science ®Google Scholar
• Han, D.F.; Zhou, X.; Hu, M.B.; Xie, W.; Mao, Z.F.; Chen, D.E.; Liu, F.; Zheng, F. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study. Chin Med J (Engl) 2005, 118(18), 1507–1516.
   PubMed Web of Science ®Google Scholar
• Le, M.L.; Donlon, T.; Kolonel, L.N.; Henderson, B.E.; Wilkens, L.R. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005, 14(8), 1998–2003.
   PubMed Web of Science ®Google Scholar
• Lilla, C.; Risch, A.; Kropp, S.; Chang-Claude, J. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German casecontrol study. Breast Cancer Res 2005, 7(2), R229–R237.
   PubMed Web of Science ®Google Scholar
• Millikan, R.C.; Pittman, G.S.; Tse, C.K.; Duell, E.; Newman, B.; Savitz, D.; Moorman, P.G.; Boissy, R.J.; Bell, D.A. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 1998, 19(11), 1943–1947.
   PubMed Web of Science ®Google Scholar
• Thompson, P.A.; Shields, P.G.; Freudenheim, J.L.; Stone, A.; Vena, J.E.; Marshall, J.R.; Graham, S.; Laughlin, R.; Nemoto, T.; Kadlubar, F.F.; Ambrosone, C.B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998, 58(10), 2107–2110.
   PubMed Web of Science ®Google Scholar
• Mitrunen, K.; Jourenkova, N.; Kataja, V.; Eskelinen, M.; Kosma, V.M.; Benhamou, S.; Kang, D.; Vainio, H.; Uusitupa, M.; Hirvonen, A. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10(6), 635–640.
   PubMed Web of Science ®Google Scholar
• Kocabas, N.A.; Sardas, S.; Cholerton, S.; Daly, A.K.; Karakaya, A.E. Cytochrome P450 CYP1B1 and catechol-O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol 2002, 76(11), 643–649.
   PubMed Web of Science ®Google Scholar
• Kang, D. Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women. J Biochem Mol Biol 2003, 36(1), 28–34.
   PubMedGoogle Scholar
• Park, S.K.; Yim, D.S.; Yoon, K.S.; Choi, I.M.; Choi, J.Y.; Yoo, K.Y.; Noh, D.Y.; Choe, K.J.; Ahn, S.H.; Hirvonen, A.; Kang, D. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk. Breast Cancer Res Treat 2004, 88(1), 55–62.
   PubMed Web of Science ®Google Scholar
• Sazci, A.; Ergul, E.; Utkan, N.Z.; Canturk, N.Z.; Kaya, G. Catechol-Omethyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients. Toxicology 2004, 204(2–3), 197–202.
   PubMed Web of Science ®Google Scholar
• Onay, V.U.; Briollais, L.; Knight, J.A.; Shi, E.; Wang, Y.; Wells, S.; Li, H.; Rajendram, I.; Andrulis, I.L.; Ozcelik, H. SNP-SNP interactions in breast cancer susceptibility. BMC Cancer 2006, 6, 114.
   PubMedGoogle Scholar
• Akisik, E.; Dalay, N. Functional polymorphism of thymidylate synthase, but not of the COMT and IL-1B genes, is associated with breast cancer. J Clin Lab Anal 2007, 21(2), 97–102.
   PubMed Web of Science ®Google Scholar
• Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C.; Stefanick, M.L.; Jackson, R.D.; Beresford, S.A.; Howard, B.V.; Johnson, K.C.; Kotchen, J.M.; Ockene, J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3), 321–333.
   PubMed Web of Science ®Google Scholar